Loading...
XNYS
CAH
Market cap54bUSD
Jul 10, Last price  
235.80USD
1D
-1.43%
1Q
8.47%
Jan 2017
224.82%
Name

Cardinal Health Inc

Chart & Performance

D1W1MN
XNYS:CAH chart
P/E
35.38
P/S
0.25
EPS
6.67
Div Yield, %
0.87%
Shrs. gr., 5y
-3.75%
Rev. gr., 5y
7.80%
Revenues
222.58b
-1.87%
79,664,200,00086,852,000,00087,408,200,00095,991,500,00098,503,000,000102,644,000,000107,552,000,000101,093,000,00091,084,000,000102,531,000,000121,546,000,000129,976,000,000136,809,000,000145,534,000,000152,922,000,000162,467,000,000181,326,000,000204,979,000,000226,827,000,000222,578,000,000
Net income
1.56b
+83.22%
1,000,100,0001,931,100,0001,300,600,0001,151,600,000642,200,000959,000,0001,069,000,000334,000,0001,166,000,0001,215,000,0001,427,000,0001,288,000,000256,000,0001,363,000,000-3,693,000,000611,000,000-938,000,000330,000,000852,000,0001,561,000,000
CFO
2.40b
-36.28%
2,140,300,0001,223,100,0001,512,100,0001,567,300,0002,134,100,0001,394,600,0001,176,000,0001,727,000,0002,524,000,0002,540,000,0002,971,000,0001,184,000,0002,768,000,0002,722,000,0001,960,000,0002,429,000,0003,122,000,0002,844,000,0003,762,000,0002,397,000,000
Dividend
Jan 02, 20260.5107 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cardinal Health, Inc. functions as a comprehensive provider of healthcare services and products, extending its reach across the United States, Canada, Europe, Asia, and other international markets. The company delivers tailored solutions to a diverse client base, encompassing hospitals, healthcare systems, pharmacies, outpatient surgical centers, clinical testing facilities, physician's offices, and individuals receiving care at home. Its operations are bifurcated into two principal divisions: Pharmaceutical and Medical. The Pharmaceutical division is responsible for the distribution of a broad spectrum of pharmaceuticals, including proprietary and generic medications, specialty drugs, and over-the-counter health items. It further extends its services to pharmaceutical manufacturers and healthcare providers, specifically supporting specialized pharmaceutical products. This segment also manages nuclear pharmacies and facilities for radiopharmaceutical production, in addition to repackaging generic and OTC health products. Moreover, it delivers medication therapy management and patient outcomes improvement services to hospitals, various healthcare practitioners, and insurers, alongside providing comprehensive pharmacy management for hospitals. The Medical division concentrates on the manufacturing, procurement, and distribution of Cardinal Health's proprietary range of medical, surgical, and laboratory equipment and supplies. This extensive product portfolio features items such as examination and surgical gloves; needles, syringes, and sharps disposal units; compression wear; incontinence supplies; nutritional delivery systems; wound care products; single-use surgical drapes, gowns, and apparel; fluid suction and collection apparatus; urological supplies; operating room essentials; and electrode product lines. Furthermore, this segment distributes a wide array of nationally recognized medical, surgical, and laboratory products. It also offers critical supply chain services and solutions to hospitals, outpatient surgical centers, clinical laboratories, and other healthcare providers, while also producing and selling pre-assembled sterile and non-sterile procedure kits. Established in 1979, Cardinal Health maintains its corporate headquarters in Dublin, Ohio.
IPO date
Aug 04, 1983
Employees
47,040
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT